+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptoids Market - Global Forecast 2025-2030- Product Image
Peptoids Market - Global Forecast 2025-2030- Product Image
Sale

Peptoids Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123686
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives in the chemical, life sciences, and pharmaceutical sectors are closely monitoring the peptoids market as its innovative materials and advanced synthesis methods drive industry transformation. This report delivers a comprehensive analysis of current trends, regulatory shifts, and competitive strategies defining the global peptoids sector.

Market Snapshot: Peptoids Market Insights and Growth Trajectory

The global peptoids market has entered a phase of significant expansion, with robust growth supported by heightened R&D activity, new synthesis platforms, and rising collaborations between industry and academia. Recent years have seen accelerated adoption across key applications, driven by the sector’s enhanced protease resistance and customizable properties. As an increasing number of leading firms target novel biomaterial and therapeutic innovations, the market’s momentum is reinforced by regulatory clarity and sizable private as well as public investment.

Scope & Segmentation of the Peptoids Market

This report offers actionable segmentation and comprehensive regional coverage, revealing drivers and opportunities relevant to a diverse stakeholder mix. The assessment spans market types, applications, end users, synthesis techniques, and global regions:

  • Type: Cyclic, Linear
  • Application: Biomedical Research; Diagnostics (Biomarker Detection, Imaging Agents); Drug Delivery (Controlled Release, Hydrogel-Based Carriers, Polymer-Based Carriers, Targeted Delivery); Drug Discovery (High-Throughput Screening, Molecular Modeling); Tissue Engineering (Cell Adhesion, Scaffold Functionalization)
  • End User: Academic & Research Institutes (Government Laboratories, Universities); Biotechnology Companies (Diagnostics, Therapeutics); CROs (Clinical, Preclinical); Pharmaceutical Companies (Big Pharma, Generic Pharma)
  • Synthesis Method: Solid-Phase Synthesis (Boc Chemistry, Fmoc Chemistry); Solution-Phase Synthesis (Conventional Heating, Microwave-Assisted)
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, select EMEA countries); Asia-Pacific (China, India, Japan, Australia, select APAC countries)
  • Companies Profiled: Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Bachem Holding AG, GenScript Biotech Corporation, Pepscan Presto B.V., CPC Scientific Inc., Peptide 2.0 Inc., Peptides International LLC, NovoPro Bioscience Co., Ltd., JPT Peptide Technologies GmbH

Key Takeaways for Senior Decision-Makers

  • Technological innovation, such as automated solid-phase synthesis and high-throughput screening, is expanding peptoid libraries and accelerating adoption in biomedical and diagnostic applications.
  • Strategic partnerships between academic institutions, industry, and contract research organizations are enabling rapid translation of discoveries into preclinical development and commercial offerings.
  • Regulatory developments highlight greater attention to reproducibility, impurity control, and long-term stability, requiring early investment in quality-by-design and risk assessment protocols.
  • The market’s segmentation shows a distinct alignment between application area and synthesis technique, supporting tailored strategies for entry and growth.
  • Regional dynamics reveal that markets in the Americas benefit from strong innovation infrastructure, EMEA regions focus on harmonization and collaboration, and Asia-Pacific leverages production scalability and cost advantages.
  • Customization and end-to-end solutions are increasingly sought after, as firms respond to both complex client requirements and evolving regulatory standards.

Tariff Impact: Strategic Adjustments Post-2025 U.S. Duty Changes

The imposition of tariffs by the United States on imported intermediates and raw materials in 2025 has directly altered cost structures and global sourcing within the peptoids market. Organizations have responded with adaptive procurement strategies, increased nearshoring, domestic production of key monomers and resins, and renegotiated supplier agreements. Elevated import costs have also encouraged operational improvements through process optimization, strategic inventory management, and restructuring of distribution channels, ensuring a stable supply chain and protection of margins amid ongoing global trade uncertainties.

Methodology & Data Sources

The analysis integrates primary interviews with R&D and regulatory leaders, alongside secondary research from journals, industry whitepapers, and patent databases. Quantitative data are validated through robust statistical analysis, scenario modeling, and peer review by subject matter experts, ensuring reliability in every conclusion.

Why This Report Matters to Enterprise Leaders

  • Enables informed investment and R&D allocation by illuminating evolving technology, supply chain, and competitive landscapes in the peptoids market.
  • Supports strategic planning by providing actionable regional, application, and synthesis method insights, as well as risk mitigation guidance in response to tariff and regulatory shifts.
  • Positions executive teams for long-term, sustainable growth by benchmarking leading vendors, collaborative models, and innovation pipelines.

Conclusion: Strategic Outlook for the Global Peptoids Market

This report provides senior leaders with a precise roadmap for navigating the evolving peptoids industry. Effective adaptation to new technologies, partnerships, and regulatory landscapes will underpin resilience and secure competitive advantage globally.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of peptoid-based scaffolds for targeted drug delivery in oncology applications
5.2. Expansion of automated combinatorial peptoid synthesis platforms for rapid library generation
5.3. Growing adoption of peptoid-based antimicrobial agents to combat multidrug-resistant bacterial strains
5.4. Development of cell-permeable peptoid inhibitors targeting intracellular protein-protein interactions in oncology
5.5. Strategic collaborations between biotech startups and pharma companies to advance peptoid therapeutic pipelines
5.6. Emerging computational design approaches to optimize peptoid sequence specificity and binding affinity
5.7. Increasing patent activity around peptoid therapeutics for neurodegenerative disease treatment pipelines
5.8. Application of peptoid-based polymer coatings to enhance medical implant biocompatibility and longevity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peptoids Market, by Type
8.1. Introduction
8.2. Cyclic
8.3. Linear
9. Peptoids Market, by Application
9.1. Introduction
9.2. Biomedical Research
9.2.1. Biological Assays
9.2.2. Mechanistic Studies
9.3. Diagnostics
9.3.1. Biomarker Detection
9.3.2. Imaging Agents
9.4. Drug Delivery
9.4.1. Controlled Release
9.4.1.1. Hydrogel-Based Carriers
9.4.1.2. Polymer-Based Carriers
9.4.2. Targeted Delivery
9.5. Drug Discovery
9.5.1. High-Throughput Screening
9.5.2. Molecular Modeling
9.6. Tissue Engineering
9.6.1. Cell Adhesion
9.6.2. Scaffold Functionalization
10. Peptoids Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Laboratories
10.2.2. Universities
10.3. Biotechnology Companies
10.3.1. Diagnostics
10.3.2. Therapeutics
10.4. CROs
10.4.1. Clinical
10.4.2. Preclinical
10.5. Pharmaceutical Companies
10.5.1. Big Pharma
10.5.2. Generic Pharma
11. Peptoids Market, by Synthesis Method
11.1. Introduction
11.2. Solid-Phase Synthesis
11.2.1. Boc Chemistry
11.2.2. Fmoc Chemistry
11.3. Solution-Phase Synthesis
11.3.1. Conventional Heating
11.3.2. Microwave-Assisted
12. Americas Peptoids Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Peptoids Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Peptoids Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sigma-Aldrich Co. LLC
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Bachem Holding AG
15.3.4. GenScript Biotech Corporation
15.3.5. Pepscan Presto B.V.
15.3.6. CPC Scientific Inc.
15.3.7. Peptide 2.0 Inc.
15.3.8. Peptides International LLC
15.3.9. NovoPro Bioscience Co., Ltd.
15.3.10. JPT Peptide Technologies GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PEPTOIDS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTOIDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PEPTOIDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PEPTOIDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PEPTOIDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PEPTOIDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PEPTOIDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PEPTOIDS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PEPTOIDS MARKET: RESEARCHAI
FIGURE 24. PEPTOIDS MARKET: RESEARCHSTATISTICS
FIGURE 25. PEPTOIDS MARKET: RESEARCHCONTACTS
FIGURE 26. PEPTOIDS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PEPTOIDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEPTOIDS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PEPTOIDS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTOIDS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PEPTOIDS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PEPTOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTOIDS MARKET SIZE, BY CYCLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PEPTOIDS MARKET SIZE, BY CYCLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTOIDS MARKET SIZE, BY LINEAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PEPTOIDS MARKET SIZE, BY LINEAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTOIDS MARKET SIZE, BY BIOLOGICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PEPTOIDS MARKET SIZE, BY BIOLOGICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTOIDS MARKET SIZE, BY MECHANISTIC STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PEPTOIDS MARKET SIZE, BY MECHANISTIC STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMARKER DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PEPTOIDS MARKET SIZE, BY BIOMARKER DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PEPTOIDS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PEPTOIDS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PEPTOIDS MARKET SIZE, BY HYDROGEL-BASED CARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PEPTOIDS MARKET SIZE, BY HYDROGEL-BASED CARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PEPTOIDS MARKET SIZE, BY POLYMER-BASED CARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PEPTOIDS MARKET SIZE, BY POLYMER-BASED CARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PEPTOIDS MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PEPTOIDS MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PEPTOIDS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PEPTOIDS MARKET SIZE, BY HIGH-THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PEPTOIDS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PEPTOIDS MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PEPTOIDS MARKET SIZE, BY CELL ADHESION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PEPTOIDS MARKET SIZE, BY CELL ADHESION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PEPTOIDS MARKET SIZE, BY SCAFFOLD FUNCTIONALIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PEPTOIDS MARKET SIZE, BY SCAFFOLD FUNCTIONALIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PEPTOIDS MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PEPTOIDS MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PEPTOIDS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PEPTOIDS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PEPTOIDS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PEPTOIDS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PEPTOIDS MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PEPTOIDS MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PEPTOIDS MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PEPTOIDS MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PEPTOIDS MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PEPTOIDS MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PEPTOIDS MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PEPTOIDS MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PEPTOIDS MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PEPTOIDS MARKET SIZE, BY BOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PEPTOIDS MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PEPTOIDS MARKET SIZE, BY FMOC CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PEPTOIDS MARKET SIZE, BY CONVENTIONAL HEATING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PEPTOIDS MARKET SIZE, BY CONVENTIONAL HEATING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PEPTOIDS MARKET SIZE, BY MICROWAVE-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PEPTOIDS MARKET SIZE, BY MICROWAVE-ASSISTED, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PEPTOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PEPTOIDS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PEPTOIDS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 183. CANADA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. CANADA PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. CANADA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 188. CANADA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 189. CANADA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 190. CANADA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 191. CANADA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 192. CANADA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 193. CANADA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 194. CANADA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 195. CANADA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 196. CANADA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 197. CANADA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 198. CANADA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 199. CANADA PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. CANADA PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. CANADA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 202. CANADA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 203. CANADA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 204. CANADA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 205. CANADA PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 206. CANADA PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 207. CANADA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 208. CANADA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 209. CANADA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 210. CANADA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 211. CANADA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 212. CANADA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 213. CANADA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 214. CANADA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. MEXICO PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. MEXICO PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 220. MEXICO PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 221. MEXICO PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SYNTHESIS METHOD, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY SOLUTION-PHASE SYNTHESIS, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA PEPTOIDS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY BIOMEDICAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 353. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 354. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 355. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 356. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 357. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2018-2024 (USD MILLION)
TABLE 358. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY DRUG DISCOVERY, 2025-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2018-2024 (USD MILLION)
TABLE 360. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY TISSUE ENGINEERING, 2025-2030 (USD MILLION)
TABLE 361. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 364. UNITED KINGDOM PEPTOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peptoids market report include:
  • Sigma-Aldrich Co. LLC
  • Thermo Fisher Scientific Inc.
  • Bachem Holding AG
  • GenScript Biotech Corporation
  • Pepscan Presto B.V.
  • CPC Scientific Inc.
  • Peptide 2.0 Inc.
  • Peptides International LLC
  • NovoPro Bioscience Co., Ltd.
  • JPT Peptide Technologies GmbH

Related Reports

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2025-2030 - Product Image

AI-driven Peptide Drug Discovery Platform Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Image

Doxorubicin - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
High-throughput Peptide Synthesizer Market - Global Forecast 2025-2030 - Product Image

High-throughput Peptide Synthesizer Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030 - Product Image

Oligonucleotide Synthesis Market by Product ((Drugs (ASO, SiRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030

  • Report
  • 456 Pages
  • Global
From
Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030 - Product Image

Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030

  • Report
  • 231 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.